#Molecule to #Medicine: How Daraxonrasib is #Rewriting Pancreatic #Cancer #Drug #Development

from Broadcast Retirement Network · host Jeffrey Snyder

#thismorning | #Molecule to #Medicine: How Daraxonrasib is #Rewriting Pancreatic #Cancer #Drug #Development | Andrew R. Snyder, PhD., Monash University | #Tunein: broadcastretirementnetwork.com #Aging, #Finance, #Lifestyle, #Privacy, #Retirement, #wellness

Episode metadata supplied by the publisher feed · Published Jun 8, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

#Molecule to #Medicine: How Daraxonrasib is #Rewriting Pancreatic #Cancer #Drug #Development

0:00 11:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Broadcast Retirement Network?

This episode is 11 minutes long.

When was this Broadcast Retirement Network episode published?

This episode was published on June 8, 2026.

Can I download this Broadcast Retirement Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!